(E)-1-[(15S,19S)-15-ethyl-1,11-diazapentacyclo[9.6.2.02,7.08,18.015,19]nonadeca-2,4,6,8(18),16-pentaen-17-yl]-N-methoxybutan-1-imine;5-[(15S,19S)-15-ethyl-1,11-diazapentacyclo[9.6.2.02,7.08,18.015,19]nonadeca-2,4,6,8(18),16-pentaen-17-yl]-3-methyl-1,2-oxazole;5-[(15S,19S)-15-ethyl-1,11-diazapentacyclo[9.6.2.02,7.08,18.015,19]nonadeca-2,4,6,8(18),16-pentaen-17-yl]-1,2-oxazole;4-[(15S,19S)-15-ethyl-1,11-diazapentacyclo[9.6.2.02,7.08,18.015,19]nonadeca-2,4,6,8(18),16-pentaen-17-yl]-1,3-thiazol-2-amine;(15S,19S)-15-ethyl-17-(7-methylimidazo[1,2-a]pyridin-2-yl)-1,11-diazapentacyclo[9.6.2.02,7.08,18.015,19]nonadeca-2,4,6,8(18),16-pentaene;(15S,19S)-15-ethyl-17-(1-methylpyrazol-3-yl)-1,11-diazapentacyclo[9.6.2.02,7.08,18.015,19]nonadeca-2,4,6,8(18),16-pentaene;(15S,19S)-15-ethyl-17-(2-methylpyrazol-3-yl)-1,11-diazapentacyclo[9.6.2.02,7.08,18.015,19]nonadeca-2,4,6,8(18),16-pentaene

C164H183N25O3S — CID 172960102

IUPAC(E)-1-[(15S,19S)-15-ethyl-1,11-diazapentacyclo[9.6.2.02,7.08,18.015,19]nonadeca-2,4,6,8(18),16-pentaen-17-yl]-N-methoxybutan-1-imine;5-[(15S,19S)-15-ethyl-1,11-diazapentacyclo[9.6.2.02,7.08,18.015,19]nonadeca-2,4,6,8(18),16-pentaen-17-yl]-3-methyl-1,2-oxazole;5-[(15S,19S)-15-ethyl-1,11-diazapentacyclo[9.6.2.02,7.08,18.015,19]nonadeca-2,4,6,8(18),16-pentaen-17-yl]-1,2-oxazole;4-[(15S,19S)-15-ethyl-1,11-diazapentacyclo[9.6.2.02,7.08,18.015,19]nonadeca-2,4,6,8(18),16-pentaen-17-yl]-1,3-thiazol-2-amine;(15S,19S)-15-ethyl-17-(7-methylimidazo[1,2-a]pyridin-2-yl)-1,11-diazapentacyclo[9.6.2.02,7.08,18.015,19]nonadeca-2,4,6,8(18),16-pentaene;(15S,19S)-15-ethyl-17-(1-methylpyrazol-3-yl)-1,11-diazapentacyclo[9.6.2.02,7.08,18.015,19]nonadeca-2,4,6,8(18),16-pentaene;(15S,19S)-15-ethyl-17-(2-methylpyrazol-3-yl)-1,11-diazapentacyclo[9.6.2.02,7.08,18.015,19]nonadeca-2,4,6,8(18),16-pentaene
SMILESCCC/C(=N\OC)C1=C[C@]2(CC)CCCN3CCc4c(n1c1ccccc41)[C@@H]32.CC[C@@]12C=C(c3cc(C)no3)n3c4c(c5ccccc53)CCN(CCC1)[C@H]42.CC[C@@]12C=C(c3ccn(C)n3)n3c4c(c5ccccc53)CCN(CCC1)[C@H]42.CC[C@@]12C=C(c3ccnn3C)n3c4c(c5ccccc53)CCN(CCC1)[C@H]42.CC[C@@]12C=C(c3ccno3)n3c4c(c5ccccc53)CCN(CCC1)[C@H]42.CC[C@@]12C=C(c3cn4ccc(C)cc4n3)n3c4c(c5ccccc53)CCN(CCC1)[C@H]42.CC[C@@]12C=C(c3csc(N)n3)n3c4c(c5ccccc53)CCN(CCC1)[C@H]42
InChIInChI=1S/C27H28N4.C24H31N3O.2C23H26N4.C23H25N3O.C22H24N4S.C22H23N3O/c1-3-27-11-6-12-29-14-10-20-19-7-4-5-8-22(19)31(25(20)26(27)29)23(16-27)21-17-30-13-9-18(2)15-24(30)28-21;1-4-9-19(25-28-3)21-16-24(5-2)13-8-14-26-15-12-18-17-10-6-7-11-20(17)27(21)22(18)23(24)26;1-3-23-11-6-13-26-14-10-17-16-7-4-5-8-18(16)27(21(17)22(23)26)20(15-23)19-9-12-24-25(19)2;1-3-23-11-6-12-26-14-9-17-16-7-4-5-8-19(16)27(21(17)22(23)26)20(15-23)18-10-13-25(2)24-18;1-3-23-10-6-11-25-12-9-17-16-7-4-5-8-18(16)26(21(17)22(23)25)19(14-23)20-13-15(2)24-27-20;1-2-22-9-5-10-25-11-8-15-14-6-3-4-7-17(14)26(19(15)20(22)25)18(12-22)16-13-27-21(23)24-16;1-2-22-10-5-12-24-13-9-16-15-6-3-4-7-17(15)25(20(16)21(22)24)18(14-22)19-8-11-23-26-19/h4-5,7-9,13,15-17,26H,3,6,10-12,14H2,1-2H3;6-7,10-11,16,23H,4-5,8-9,12-15H2,1-3H3;4-5,7-9,12,15,22H,3,6,10-11,13-14H2,1-2H3;4-5,7-8,10,13,15,22H,3,6,9,11-12,14H2,1-2H3;4-5,7-8,13-14,22H,3,6,9-12H2,1-2H3;3-4,6-7,12-13,20H,2,5,8-11H2,1H3,(H2,23,24);3-4,6-8,11,14,21H,2,5,9-10,12-13H2,1H3/b;25-19+;;;;;/t26-,27+;23-,24+;3*22-,23+;20-,22+;21-,22+/m1111111/s1
InChIKeyXDJFLYWKOGDYCF-XTEAMZODSA-N
MW2584.51 g/mol
LogP33.93
Rot. Bonds17

About (E)-1-[(15S,19S)-15-ethyl-1,11-diazapentacyclo[9.6.2.02,7.08,18.015,19]nonadeca-2,4,6,8(18),16-pentaen-17-yl]-N-methoxybutan-1-imine;5-[(15S,19S)-15-ethyl-1,11-diazapentacyclo[9.6.2.02,7.08,18.015,19]nonadeca-2,4,6,8(18),16-pentaen-17-yl]-3-methyl-1,2-oxazole;5-[(15S,19S)-15-ethyl-1,11-diazapentacyclo[9.6.2.02,7.08,18.015,19]nonadeca-2,4,6,8(18),16-pentaen-17-yl]-1,2-oxazole;4-[(15S,19S)-15-ethyl-1,11-diazapentacyclo[9.6.2.02,7.08,18.015,19]nonadeca-2,4,6,8(18),16-pentaen-17-yl]-1,3-thiazol-2-amine;(15S,19S)-15-ethyl-17-(7-methylimidazo[1,2-a]pyridin-2-yl)-1,11-diazapentacyclo[9.6.2.02,7.08,18.015,19]nonadeca-2,4,6,8(18),16-pentaene;(15S,19S)-15-ethyl-17-(1-methylpyrazol-3-yl)-1,11-diazapentacyclo[9.6.2.02,7.08,18.015,19]nonadeca-2,4,6,8(18),16-pentaene;(15S,19S)-15-ethyl-17-(2-methylpyrazol-3-yl)-1,11-diazapentacyclo[9.6.2.02,7.08,18.015,19]nonadeca-2,4,6,8(18),16-pentaene

(E)-1-[(15S,19S)-15-ethyl-1,11-diazapentacyclo[9.6.2.02,7.08,18.015,19]nonadeca-2,4,6,8(18),16-pentaen-17-yl]-N-methoxybutan-1-imine;5-[(15S,19S)-15-ethyl-1,11-diazapentacyclo[9.6.2.02,7.08,18.015,19]nonadeca-2,4,6,8(18),16-pentaen-17-yl]-3-methyl-1,2-oxazole;5-[(15S,19S)-15-ethyl-1,11-diazapentacyclo[9.6.2.02,7.08,18.015,19]nonadeca-2,4,6,8(18),16-pentaen-17-yl]-1,2-oxazole;4-[(15S,19S)-15-ethyl-1,11-diazapentacyclo[9.6.2.02,7.08,18.015,19]nonadeca-2,4,6,8(18),16-pentaen-17-yl]-1,3-thiazol-2-amine;(15S,19S)-15-ethyl-17-(7-methylimidazo[1,2-a]pyridin-2-yl)-1,11-diazapentacyclo[9.6.2.02,7.08,18.015,19]nonadeca-2,4,6,8(18),16-pentaene;(15S,19S)-15-ethyl-17-(1-methylpyrazol-3-yl)-1,11-diazapentacyclo[9.6.2.02,7.08,18.015,19]nonadeca-2,4,6,8(18),16-pentaene;(15S,19S)-15-ethyl-17-(2-methylpyrazol-3-yl)-1,11-diazapentacyclo[9.6.2.02,7.08,18.015,19]nonadeca-2,4,6,8(18),16-pentaene (PubChem CID 172960102) has the molecular formula C164H183N25O3S and a molecular weight of 2584.51 g/mol. Its IUPAC name is (E)-1-[(15S,19S)-15-ethyl-1,11-diazapentacyclo[9.6.2.02,7.08,18.015,19]nonadeca-2,4,6,8(18),16-pentaen-17-yl]-N-methoxybutan-1-imine;5-[(15S,19S)-15-ethyl-1,11-diazapentacyclo[9.6.2.02,7.08,18.015,19]nonadeca-2,4,6,8(18),16-pentaen-17-yl]-3-methyl-1,2-oxazole;5-[(15S,19S)-15-ethyl-1,11-diazapentacyclo[9.6.2.02,7.08,18.015,19]nonadeca-2,4,6,8(18),16-pentaen-17-yl]-1,2-oxazole;4-[(15S,19S)-15-ethyl-1,11-diazapentacyclo[9.6.2.02,7.08,18.015,19]nonadeca-2,4,6,8(18),16-pentaen-17-yl]-1,3-thiazol-2-amine;(15S,19S)-15-ethyl-17-(7-methylimidazo[1,2-a]pyridin-2-yl)-1,11-diazapentacyclo[9.6.2.02,7.08,18.015,19]nonadeca-2,4,6,8(18),16-pentaene;(15S,19S)-15-ethyl-17-(1-methylpyrazol-3-yl)-1,11-diazapentacyclo[9.6.2.02,7.08,18.015,19]nonadeca-2,4,6,8(18),16-pentaene;(15S,19S)-15-ethyl-17-(2-methylpyrazol-3-yl)-1,11-diazapentacyclo[9.6.2.02,7.08,18.015,19]nonadeca-2,4,6,8(18),16-pentaene.

Molecular Properties

Compound Name(E)-1-[(15S,19S)-15-ethyl-1,11-diazapentacyclo[9.6.2.02,7.08,18.015,19]nonadeca-2,4,6,8(18),16-pentaen-17-yl]-N-methoxybutan-1-imine;5-[(15S,19S)-15-ethyl-1,11-diazapentacyclo[9.6.2.02,7.08,18.015,19]nonadeca-2,4,6,8(18),16-pentaen-17-yl]-3-methyl-1,2-oxazole;5-[(15S,19S)-15-ethyl-1,11-diazapentacyclo[9.6.2.02,7.08,18.015,19]nonadeca-2,4,6,8(18),16-pentaen-17-yl]-1,2-oxazole;4-[(15S,19S)-15-ethyl-1,11-diazapentacyclo[9.6.2.02,7.08,18.015,19]nonadeca-2,4,6,8(18),16-pentaen-17-yl]-1,3-thiazol-2-amine;(15S,19S)-15-ethyl-17-(7-methylimidazo[1,2-a]pyridin-2-yl)-1,11-diazapentacyclo[9.6.2.02,7.08,18.015,19]nonadeca-2,4,6,8(18),16-pentaene;(15S,19S)-15-ethyl-17-(1-methylpyrazol-3-yl)-1,11-diazapentacyclo[9.6.2.02,7.08,18.015,19]nonadeca-2,4,6,8(18),16-pentaene;(15S,19S)-15-ethyl-17-(2-methylpyrazol-3-yl)-1,11-diazapentacyclo[9.6.2.02,7.08,18.015,19]nonadeca-2,4,6,8(18),16-pentaene
PubChem CID172960102
Molecular FormulaC164H183N25O3S
Molecular Weight2584.51 g/mol
Exact Mass2582.47
IUPAC Name(E)-1-[(15S,19S)-15-ethyl-1,11-diazapentacyclo[9.6.2.02,7.08,18.015,19]nonadeca-2,4,6,8(18),16-pentaen-17-yl]-N-methoxybutan-1-imine;5-[(15S,19S)-15-ethyl-1,11-diazapentacyclo[9.6.2.02,7.08,18.015,19]nonadeca-2,4,6,8(18),16-pentaen-17-yl]-3-methyl-1,2-oxazole;5-[(15S,19S)-15-ethyl-1,11-diazapentacyclo[9.6.2.02,7.08,18.015,19]nonadeca-2,4,6,8(18),16-pentaen-17-yl]-1,2-oxazole;4-[(15S,19S)-15-ethyl-1,11-diazapentacyclo[9.6.2.02,7.08,18.015,19]nonadeca-2,4,6,8(18),16-pentaen-17-yl]-1,3-thiazol-2-amine;(15S,19S)-15-ethyl-17-(7-methylimidazo[1,2-a]pyridin-2-yl)-1,11-diazapentacyclo[9.6.2.02,7.08,18.015,19]nonadeca-2,4,6,8(18),16-pentaene;(15S,19S)-15-ethyl-17-(1-methylpyrazol-3-yl)-1,11-diazapentacyclo[9.6.2.02,7.08,18.015,19]nonadeca-2,4,6,8(18),16-pentaene;(15S,19S)-15-ethyl-17-(2-methylpyrazol-3-yl)-1,11-diazapentacyclo[9.6.2.02,7.08,18.015,19]nonadeca-2,4,6,8(18),16-pentaene
SMILESCCC/C(=N\OC)C1=C[C@]2(CC)CCCN3CCc4c(n1c1ccccc41)[C@@H]32.CC[C@@]12C=C(c3cc(C)no3)n3c4c(c5ccccc53)CCN(CCC1)[C@H]42.CC[C@@]12C=C(c3ccn(C)n3)n3c4c(c5ccccc53)CCN(CCC1)[C@H]42.CC[C@@]12C=C(c3ccnn3C)n3c4c(c5ccccc53)CCN(CCC1)[C@H]42.CC[C@@]12C=C(c3ccno3)n3c4c(c5ccccc53)CCN(CCC1)[C@H]42.CC[C@@]12C=C(c3cn4ccc(C)cc4n3)n3c4c(c5ccccc53)CCN(CCC1)[C@H]42.CC[C@@]12C=C(c3csc(N)n3)n3c4c(c5ccccc53)CCN(CCC1)[C@H]42
InChIInChI=1S/C27H28N4.C24H31N3O.2C23H26N4.C23H25N3O.C22H24N4S.C22H23N3O/c1-3-27-11-6-12-29-14-10-20-19-7-4-5-8-22(19)31(25(20)26(27)29)23(16-27)21-17-30-13-9-18(2)15-24(30)28-21;1-4-9-19(25-28-3)21-16-24(5-2)13-8-14-26-15-12-18-17-10-6-7-11-20(17)27(21)22(18)23(24)26;1-3-23-11-6-13-26-14-10-17-16-7-4-5-8-18(16)27(21(17)22(23)26)20(15-23)19-9-12-24-25(19)2;1-3-23-11-6-12-26-14-9-17-16-7-4-5-8-19(16)27(21(17)22(23)26)20(15-23)18-10-13-25(2)24-18;1-3-23-10-6-11-25-12-9-17-16-7-4-5-8-18(16)26(21(17)22(23)25)19(14-23)20-13-15(2)24-27-20;1-2-22-9-5-10-25-11-8-15-14-6-3-4-7-17(14)26(19(15)20(22)25)18(12-22)16-13-27-21(23)24-16;1-2-22-10-5-12-24-13-9-16-15-6-3-4-7-17(15)25(20(16)21(22)24)18(14-22)19-8-11-23-26-19/h4-5,7-9,13,15-17,26H,3,6,10-12,14H2,1-2H3;6-7,10-11,16,23H,4-5,8-9,12-15H2,1-3H3;4-5,7-9,12,15,22H,3,6,10-11,13-14H2,1-2H3;4-5,7-8,10,13,15,22H,3,6,9,11-12,14H2,1-2H3;4-5,7-8,13-14,22H,3,6,9-12H2,1-2H3;3-4,6-7,12-13,20H,2,5,8-11H2,1H3,(H2,23,24);3-4,6-8,11,14,21H,2,5,9-10,12-13H2,1H3/b;25-19+;;;;;/t26-,27+;23-,24+;3*22-,23+;20-,22+;21-,22+/m1111111/s1
InChIKeyXDJFLYWKOGDYCF-XTEAMZODSA-N
XLogP33.93
TPSA222.69 Ų
H-Bond Donors1
H-Bond Acceptors29
Rotatable Bonds17
Heavy Atoms193
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5002584.51
LogP ≤ 533.93
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 1029

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'imine_1', 'substructure': 'N/A'}, {'alert_name': 'Oxygen-nitrogen_single_bond', 'substructure': 'N/A'}

Analyze (E)-1-[(15S,19S)-15-ethyl-1,11-diazapentacyclo[9.6.2.02,7.08,18.015,19]nonadeca-2,4,6,8(18),16-pentaen-17-yl]-N-methoxybutan-1-imine;5-[(15S,19S)-15-ethyl-1,11-diazapentacyclo[9.6.2.02,7.08,18.015,19]nonadeca-2,4,6,8(18),16-pentaen-17-yl]-3-methyl-1,2-oxazole;5-[(15S,19S)-15-ethyl-1,11-diazapentacyclo[9.6.2.02,7.08,18.015,19]nonadeca-2,4,6,8(18),16-pentaen-17-yl]-1,2-oxazole;4-[(15S,19S)-15-ethyl-1,11-diazapentacyclo[9.6.2.02,7.08,18.015,19]nonadeca-2,4,6,8(18),16-pentaen-17-yl]-1,3-thiazol-2-amine;(15S,19S)-15-ethyl-17-(7-methylimidazo[1,2-a]pyridin-2-yl)-1,11-diazapentacyclo[9.6.2.02,7.08,18.015,19]nonadeca-2,4,6,8(18),16-pentaene;(15S,19S)-15-ethyl-17-(1-methylpyrazol-3-yl)-1,11-diazapentacyclo[9.6.2.02,7.08,18.015,19]nonadeca-2,4,6,8(18),16-pentaene;(15S,19S)-15-ethyl-17-(2-methylpyrazol-3-yl)-1,11-diazapentacyclo[9.6.2.02,7.08,18.015,19]nonadeca-2,4,6,8(18),16-pentaene with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (E)-1-[(15S,19S)-15-ethyl-1,11-diazapentacyclo[9.6.2.02,7.08,18.015,19]nonadeca-2,4,6,8(18),16-pentaen-17-yl]-N-methoxybutan-1-imine;5-[(15S,19S)-15-ethyl-1,11-diazapentacyclo[9.6.2.02,7.08,18.015,19]nonadeca-2,4,6,8(18),16-pentaen-17-yl]-3-methyl-1,2-oxazole;5-[(15S,19S)-15-ethyl-1,11-diazapentacyclo[9.6.2.02,7.08,18.015,19]nonadeca-2,4,6,8(18),16-pentaen-17-yl]-1,2-oxazole;4-[(15S,19S)-15-ethyl-1,11-diazapentacyclo[9.6.2.02,7.08,18.015,19]nonadeca-2,4,6,8(18),16-pentaen-17-yl]-1,3-thiazol-2-amine;(15S,19S)-15-ethyl-17-(7-methylimidazo[1,2-a]pyridin-2-yl)-1,11-diazapentacyclo[9.6.2.02,7.08,18.015,19]nonadeca-2,4,6,8(18),16-pentaene;(15S,19S)-15-ethyl-17-(1-methylpyrazol-3-yl)-1,11-diazapentacyclo[9.6.2.02,7.08,18.015,19]nonadeca-2,4,6,8(18),16-pentaene;(15S,19S)-15-ethyl-17-(2-methylpyrazol-3-yl)-1,11-diazapentacyclo[9.6.2.02,7.08,18.015,19]nonadeca-2,4,6,8(18),16-pentaene?
The IUPAC name of (E)-1-[(15S,19S)-15-ethyl-1,11-diazapentacyclo[9.6.2.02,7.08,18.015,19]nonadeca-2,4,6,8(18),16-pentaen-17-yl]-N-methoxybutan-1-imine;5-[(15S,19S)-15-ethyl-1,11-diazapentacyclo[9.6.2.02,7.08,18.015,19]nonadeca-2,4,6,8(18),16-pentaen-17-yl]-3-methyl-1,2-oxazole;5-[(15S,19S)-15-ethyl-1,11-diazapentacyclo[9.6.2.02,7.08,18.015,19]nonadeca-2,4,6,8(18),16-pentaen-17-yl]-1,2-oxazole;4-[(15S,19S)-15-ethyl-1,11-diazapentacyclo[9.6.2.02,7.08,18.015,19]nonadeca-2,4,6,8(18),16-pentaen-17-yl]-1,3-thiazol-2-amine;(15S,19S)-15-ethyl-17-(7-methylimidazo[1,2-a]pyridin-2-yl)-1,11-diazapentacyclo[9.6.2.02,7.08,18.015,19]nonadeca-2,4,6,8(18),16-pentaene;(15S,19S)-15-ethyl-17-(1-methylpyrazol-3-yl)-1,11-diazapentacyclo[9.6.2.02,7.08,18.015,19]nonadeca-2,4,6,8(18),16-pentaene;(15S,19S)-15-ethyl-17-(2-methylpyrazol-3-yl)-1,11-diazapentacyclo[9.6.2.02,7.08,18.015,19]nonadeca-2,4,6,8(18),16-pentaene (CID 172960102) is (E)-1-[(15S,19S)-15-ethyl-1,11-diazapentacyclo[9.6.2.02,7.08,18.015,19]nonadeca-2,4,6,8(18),16-pentaen-17-yl]-N-methoxybutan-1-imine;5-[(15S,19S)-15-ethyl-1,11-diazapentacyclo[9.6.2.02,7.08,18.015,19]nonadeca-2,4,6,8(18),16-pentaen-17-yl]-3-methyl-1,2-oxazole;5-[(15S,19S)-15-ethyl-1,11-diazapentacyclo[9.6.2.02,7.08,18.015,19]nonadeca-2,4,6,8(18),16-pentaen-17-yl]-1,2-oxazole;4-[(15S,19S)-15-ethyl-1,11-diazapentacyclo[9.6.2.02,7.08,18.015,19]nonadeca-2,4,6,8(18),16-pentaen-17-yl]-1,3-thiazol-2-amine;(15S,19S)-15-ethyl-17-(7-methylimidazo[1,2-a]pyridin-2-yl)-1,11-diazapentacyclo[9.6.2.02,7.08,18.015,19]nonadeca-2,4,6,8(18),16-pentaene;(15S,19S)-15-ethyl-17-(1-methylpyrazol-3-yl)-1,11-diazapentacyclo[9.6.2.02,7.08,18.015,19]nonadeca-2,4,6,8(18),16-pentaene;(15S,19S)-15-ethyl-17-(2-methylpyrazol-3-yl)-1,11-diazapentacyclo[9.6.2.02,7.08,18.015,19]nonadeca-2,4,6,8(18),16-pentaene.
What is the SMILES notation for (E)-1-[(15S,19S)-15-ethyl-1,11-diazapentacyclo[9.6.2.02,7.08,18.015,19]nonadeca-2,4,6,8(18),16-pentaen-17-yl]-N-methoxybutan-1-imine;5-[(15S,19S)-15-ethyl-1,11-diazapentacyclo[9.6.2.02,7.08,18.015,19]nonadeca-2,4,6,8(18),16-pentaen-17-yl]-3-methyl-1,2-oxazole;5-[(15S,19S)-15-ethyl-1,11-diazapentacyclo[9.6.2.02,7.08,18.015,19]nonadeca-2,4,6,8(18),16-pentaen-17-yl]-1,2-oxazole;4-[(15S,19S)-15-ethyl-1,11-diazapentacyclo[9.6.2.02,7.08,18.015,19]nonadeca-2,4,6,8(18),16-pentaen-17-yl]-1,3-thiazol-2-amine;(15S,19S)-15-ethyl-17-(7-methylimidazo[1,2-a]pyridin-2-yl)-1,11-diazapentacyclo[9.6.2.02,7.08,18.015,19]nonadeca-2,4,6,8(18),16-pentaene;(15S,19S)-15-ethyl-17-(1-methylpyrazol-3-yl)-1,11-diazapentacyclo[9.6.2.02,7.08,18.015,19]nonadeca-2,4,6,8(18),16-pentaene;(15S,19S)-15-ethyl-17-(2-methylpyrazol-3-yl)-1,11-diazapentacyclo[9.6.2.02,7.08,18.015,19]nonadeca-2,4,6,8(18),16-pentaene?
The canonical SMILES for (E)-1-[(15S,19S)-15-ethyl-1,11-diazapentacyclo[9.6.2.02,7.08,18.015,19]nonadeca-2,4,6,8(18),16-pentaen-17-yl]-N-methoxybutan-1-imine;5-[(15S,19S)-15-ethyl-1,11-diazapentacyclo[9.6.2.02,7.08,18.015,19]nonadeca-2,4,6,8(18),16-pentaen-17-yl]-3-methyl-1,2-oxazole;5-[(15S,19S)-15-ethyl-1,11-diazapentacyclo[9.6.2.02,7.08,18.015,19]nonadeca-2,4,6,8(18),16-pentaen-17-yl]-1,2-oxazole;4-[(15S,19S)-15-ethyl-1,11-diazapentacyclo[9.6.2.02,7.08,18.015,19]nonadeca-2,4,6,8(18),16-pentaen-17-yl]-1,3-thiazol-2-amine;(15S,19S)-15-ethyl-17-(7-methylimidazo[1,2-a]pyridin-2-yl)-1,11-diazapentacyclo[9.6.2.02,7.08,18.015,19]nonadeca-2,4,6,8(18),16-pentaene;(15S,19S)-15-ethyl-17-(1-methylpyrazol-3-yl)-1,11-diazapentacyclo[9.6.2.02,7.08,18.015,19]nonadeca-2,4,6,8(18),16-pentaene;(15S,19S)-15-ethyl-17-(2-methylpyrazol-3-yl)-1,11-diazapentacyclo[9.6.2.02,7.08,18.015,19]nonadeca-2,4,6,8(18),16-pentaene is CCC/C(=N\OC)C1=C[C@]2(CC)CCCN3CCc4c(n1c1ccccc41)[C@@H]32.CC[C@@]12C=C(c3cc(C)no3)n3c4c(c5ccccc53)CCN(CCC1)[C@H]42.CC[C@@]12C=C(c3ccn(C)n3)n3c4c(c5ccccc53)CCN(CCC1)[C@H]42.CC[C@@]12C=C(c3ccnn3C)n3c4c(c5ccccc53)CCN(CCC1)[C@H]42.CC[C@@]12C=C(c3ccno3)n3c4c(c5ccccc53)CCN(CCC1)[C@H]42.CC[C@@]12C=C(c3cn4ccc(C)cc4n3)n3c4c(c5ccccc53)CCN(CCC1)[C@H]42.CC[C@@]12C=C(c3csc(N)n3)n3c4c(c5ccccc53)CCN(CCC1)[C@H]42.
What is the InChIKey of (E)-1-[(15S,19S)-15-ethyl-1,11-diazapentacyclo[9.6.2.02,7.08,18.015,19]nonadeca-2,4,6,8(18),16-pentaen-17-yl]-N-methoxybutan-1-imine;5-[(15S,19S)-15-ethyl-1,11-diazapentacyclo[9.6.2.02,7.08,18.015,19]nonadeca-2,4,6,8(18),16-pentaen-17-yl]-3-methyl-1,2-oxazole;5-[(15S,19S)-15-ethyl-1,11-diazapentacyclo[9.6.2.02,7.08,18.015,19]nonadeca-2,4,6,8(18),16-pentaen-17-yl]-1,2-oxazole;4-[(15S,19S)-15-ethyl-1,11-diazapentacyclo[9.6.2.02,7.08,18.015,19]nonadeca-2,4,6,8(18),16-pentaen-17-yl]-1,3-thiazol-2-amine;(15S,19S)-15-ethyl-17-(7-methylimidazo[1,2-a]pyridin-2-yl)-1,11-diazapentacyclo[9.6.2.02,7.08,18.015,19]nonadeca-2,4,6,8(18),16-pentaene;(15S,19S)-15-ethyl-17-(1-methylpyrazol-3-yl)-1,11-diazapentacyclo[9.6.2.02,7.08,18.015,19]nonadeca-2,4,6,8(18),16-pentaene;(15S,19S)-15-ethyl-17-(2-methylpyrazol-3-yl)-1,11-diazapentacyclo[9.6.2.02,7.08,18.015,19]nonadeca-2,4,6,8(18),16-pentaene?
The InChIKey is XDJFLYWKOGDYCF-XTEAMZODSA-N. The full InChI is InChI=1S/C27H28N4.C24H31N3O.2C23H26N4.C23H25N3O.C22H24N4S.C22H23N3O/c1-3-27-11-6-12-29-14-10-20-19-7-4-5-8-22(19)31(25(20)26(27)29)23(16-27)21-17-30-13-9-18(2)15-24(30)28-21;1-4-9-19(25-28-3)21-16-24(5-2)13-8-14-26-15-12-18-17-10-6-7-11-20(17)27(21)22(18)23(24)26;1-3-23-11-6-13-26-14-10-17-16-7-4-5-8-18(16)27(21(17)22(23)26)20(15-23)19-9-12-24-25(19)2;1-3-23-11-6-12-26-14-9-17-16-7-4-5-8-19(16)27(21(17)22(23)26)20(15-23)18-10-13-25(2)24-18;1-3-23-10-6-11-25-12-9-17-16-7-4-5-8-18(16)26(21(17)22(23)25)19(14-23)20-13-15(2)24-27-20;1-2-22-9-5-10-25-11-8-15-14-6-3-4-7-17(14)26(19(15)20(22)25)18(12-22)16-13-27-21(23)24-16;1-2-22-10-5-12-24-13-9-16-15-6-3-4-7-17(15)25(20(16)21(22)24)18(14-22)19-8-11-23-26-19/h4-5,7-9,13,15-17,26H,3,6,10-12,14H2,1-2H3;6-7,10-11,16,23H,4-5,8-9,12-15H2,1-3H3;4-5,7-9,12,15,22H,3,6,10-11,13-14H2,1-2H3;4-5,7-8,10,13,15,22H,3,6,9,11-12,14H2,1-2H3;4-5,7-8,13-14,22H,3,6,9-12H2,1-2H3;3-4,6-7,12-13,20H,2,5,8-11H2,1H3,(H2,23,24);3-4,6-8,11,14,21H,2,5,9-10,12-13H2,1H3/b;25-19+;;;;;/t26-,27+;23-,24+;3*22-,23+;20-,22+;21-,22+/m1111111/s1.
What are the key properties of (E)-1-[(15S,19S)-15-ethyl-1,11-diazapentacyclo[9.6.2.02,7.08,18.015,19]nonadeca-2,4,6,8(18),16-pentaen-17-yl]-N-methoxybutan-1-imine;5-[(15S,19S)-15-ethyl-1,11-diazapentacyclo[9.6.2.02,7.08,18.015,19]nonadeca-2,4,6,8(18),16-pentaen-17-yl]-3-methyl-1,2-oxazole;5-[(15S,19S)-15-ethyl-1,11-diazapentacyclo[9.6.2.02,7.08,18.015,19]nonadeca-2,4,6,8(18),16-pentaen-17-yl]-1,2-oxazole;4-[(15S,19S)-15-ethyl-1,11-diazapentacyclo[9.6.2.02,7.08,18.015,19]nonadeca-2,4,6,8(18),16-pentaen-17-yl]-1,3-thiazol-2-amine;(15S,19S)-15-ethyl-17-(7-methylimidazo[1,2-a]pyridin-2-yl)-1,11-diazapentacyclo[9.6.2.02,7.08,18.015,19]nonadeca-2,4,6,8(18),16-pentaene;(15S,19S)-15-ethyl-17-(1-methylpyrazol-3-yl)-1,11-diazapentacyclo[9.6.2.02,7.08,18.015,19]nonadeca-2,4,6,8(18),16-pentaene;(15S,19S)-15-ethyl-17-(2-methylpyrazol-3-yl)-1,11-diazapentacyclo[9.6.2.02,7.08,18.015,19]nonadeca-2,4,6,8(18),16-pentaene?
(E)-1-[(15S,19S)-15-ethyl-1,11-diazapentacyclo[9.6.2.02,7.08,18.015,19]nonadeca-2,4,6,8(18),16-pentaen-17-yl]-N-methoxybutan-1-imine;5-[(15S,19S)-15-ethyl-1,11-diazapentacyclo[9.6.2.02,7.08,18.015,19]nonadeca-2,4,6,8(18),16-pentaen-17-yl]-3-methyl-1,2-oxazole;5-[(15S,19S)-15-ethyl-1,11-diazapentacyclo[9.6.2.02,7.08,18.015,19]nonadeca-2,4,6,8(18),16-pentaen-17-yl]-1,2-oxazole;4-[(15S,19S)-15-ethyl-1,11-diazapentacyclo[9.6.2.02,7.08,18.015,19]nonadeca-2,4,6,8(18),16-pentaen-17-yl]-1,3-thiazol-2-amine;(15S,19S)-15-ethyl-17-(7-methylimidazo[1,2-a]pyridin-2-yl)-1,11-diazapentacyclo[9.6.2.02,7.08,18.015,19]nonadeca-2,4,6,8(18),16-pentaene;(15S,19S)-15-ethyl-17-(1-methylpyrazol-3-yl)-1,11-diazapentacyclo[9.6.2.02,7.08,18.015,19]nonadeca-2,4,6,8(18),16-pentaene;(15S,19S)-15-ethyl-17-(2-methylpyrazol-3-yl)-1,11-diazapentacyclo[9.6.2.02,7.08,18.015,19]nonadeca-2,4,6,8(18),16-pentaene has a molecular weight of 2584.51 g/mol, XLogP of 33.93, 17 rotatable bonds, 1 hydrogen bond donors, and 29 hydrogen bond acceptors.
Where does this data come from?
All data for (E)-1-[(15S,19S)-15-ethyl-1,11-diazapentacyclo[9.6.2.02,7.08,18.015,19]nonadeca-2,4,6,8(18),16-pentaen-17-yl]-N-methoxybutan-1-imine;5-[(15S,19S)-15-ethyl-1,11-diazapentacyclo[9.6.2.02,7.08,18.015,19]nonadeca-2,4,6,8(18),16-pentaen-17-yl]-3-methyl-1,2-oxazole;5-[(15S,19S)-15-ethyl-1,11-diazapentacyclo[9.6.2.02,7.08,18.015,19]nonadeca-2,4,6,8(18),16-pentaen-17-yl]-1,2-oxazole;4-[(15S,19S)-15-ethyl-1,11-diazapentacyclo[9.6.2.02,7.08,18.015,19]nonadeca-2,4,6,8(18),16-pentaen-17-yl]-1,3-thiazol-2-amine;(15S,19S)-15-ethyl-17-(7-methylimidazo[1,2-a]pyridin-2-yl)-1,11-diazapentacyclo[9.6.2.02,7.08,18.015,19]nonadeca-2,4,6,8(18),16-pentaene;(15S,19S)-15-ethyl-17-(1-methylpyrazol-3-yl)-1,11-diazapentacyclo[9.6.2.02,7.08,18.015,19]nonadeca-2,4,6,8(18),16-pentaene;(15S,19S)-15-ethyl-17-(2-methylpyrazol-3-yl)-1,11-diazapentacyclo[9.6.2.02,7.08,18.015,19]nonadeca-2,4,6,8(18),16-pentaene is sourced from PubChem (CID 172960102), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).